| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.6 |